References
- Abbott F. S., Slatter J. G., Burton R., Rang G. I. Methadone metabolism in the rat in vivo. Identification of a novel formamide metabolite. Xenobictica 1985; 15: 129–140
- Bondesen S., Rasmussen S. N., Rask-Madsen J., Nielsen O. H., Lauritsen K., Binder V., Hansen S. H., Hvidberg E. F. 5-Aminosalicylic acid in the treatment of inflammatory bowel disease. Acta Medica Scandinavica 1987; 221: 227–242
- Boyland E., Manson D. The biochemistry of aromatic amines. 2-Formamido-1-naphthyl hydrogen sulphate, a metabolite of 2-naphthylamine. Biochemical Journal 1966; 99: 18–199
- Dalgliesh C. E. The synthesis of N-formyl-dl-Kynurenine, N-acetyl-dl-Kynurenine and related compounds, and observations on the synthesis of kynurenine. Journal of The Chemical Society 1952; i: 137–141
- Draper W. M. Thermospray mass spectrometry and tandem mass spectrometry of polar, urinary metabolites and metabolic conjugates. Biomedical and Environmental Mass Spectrometry 1989; 18: 767
- Fischer C., Maier K., Klotz U. Specific measurement of 5-aminosalicylic acid and its acetylated metabolite in human bile. British Journal of Clinical Pharmacology 1983; 15: 273–274
- Manning B. W., Cernigilia C. E., Federle T. W. Biotransformation of 1-nitropyrene to 1-aminopyrene and N-formyl-aminopyrene by the human intestinal microbiota. Journal of Toxicology and Environmental Health 1986; 18: 339–346
- Muecke W., Menzer R. E., Alt K. O., Richter W., Esser H. O. The metabolism of chlorotoluron in rat. Pesticide Biochemistry and Physiology 1976; 6: 430–441
- Noda A., Goromaru T., Tsubone N., Matsuyama K., Iguchi S. In vivo formation of 4-formylaminoantipyrine as a new metabolite of aminopyrine I. Chemical and Pharmaceutical Bulletin 1976a; 24: 1502–1505
- Noda A., Tsubone T., Mihara M., Goromaru T., Iguchi S. Formation of 4-formylaminopyrine as a new metabolite of aminopyrine II. Enzymatic demethylation and oxidation of aminopyrine and 4-monomethylaminopyrine. Chemical and Pharmaceutical Bulletin 1976b; 24: 3229–3231
- Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulfasalazine in the treatment of active ulcerative colitis: a randomised trial. British Medical Journal 1989; 298: 82–86
- Ross D., Farmer P. B., Gescher A., Hickman J. A., Threadgill M. D. The formation and metabolism of N-hydroxymethyl compounds III. The metabolic conversion of N-methyl and N,N-dimethylbenzamides to N-hydroxymethyl compounds. Biochemical Pharmacology 1983a; 32: 1773–1781
- Ross D., Farmer P. B., Gescher A., Hickman J. A., Threadgill M. D. The metabolism of a stable n-hydroxymethyl derivative of a N-methylamide. Life Science 1983b; 32: 597–604
- Santti R. S. S., Hopsu-Havu V. K. Transformation of carcinogenic aromatic amines by kynurenine formamidase: a detoxication mechanism. Biochemical Pharmacology 1968; 17: 1110–1113
- Schröder H., Campbell D. E. S. Absorption, metabolism, and excretion of salicylazosulfapyridine in man. Clinical Pharmacology and Therapeutics 1972; 13: 539–550
- Stillwell W. G., Lindberg C., Hartvig P. Artifacts formed in the metabolic study or pethidine. Acta Pharmaceutica Suecica 1978; 15: 71–75
- Tatsumi K., Amano H. Biotransformation of 1-nitropyrene and 2-nitrofluorene to novel metabolites, the corresponding formylamino compound, in animal bodies. Biochemical and Biophysical Research Communications 1987; 142: 376–382
- Tatsumi K., Kitamura S., Amano H., Ueda K. Comparative study on metabolic formation of N-arylformamides and N-arylacetamides from carcinogenic arylamines in mammalian species. Cancer Research 1989; 49: 2059–2064
- Tjørnelund J., Hansen S. H., Cornett C. New metabolites of the drug 5-aminosalicylic acid. I: N-β-d-Glucopyranosyl-5-aminosalicylic acid. Xenobiotica 1989; 19: 891–899